TQB3909

· Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for TQB3909, covering 2023-03-20 to 2026-01-05. Get the full timeline:

Most recent: Clinical Trial Update: A Clinical Trial of TQ05105 Tablets Combined With TQB3909 Tablets in the Treatment of Myelofibrosis (MF) [Phase 1, Phase 2]

See pricing